LifeNome Inc.’s Post

At the Precision Health Summit 2024, I had the pleasure of hosting Gabriele Allegri, VP of Precision Medicine at Johnson & Johnson. Click below to watch the video on his perspectives on how precision medicine will look like in the years to come. #precisionhealth #precisionmedicine.

Had the opportunity of participating in a thought-provoking discussion , where we delved into insights to ignite thought leadership and market innovation. The discussion centered around the theme of "Unlocking the Future: Life Sciences & Healthcare Synergy," and we covered a range of industry transformation topics. Here are some highlights from our discussion : 1) Real-world patient data to help researchers optimize clinical trials and drive discoveries in precision medicine. 2) The increased pace of digital transformation post COVID 3) How the synergies between life sciences and healthcare can increase patient centricity. Please find the link here to the discussion - https://lnkd.in/gyqJ7RHT #LifeSciences #PersonalizedCare #HIMSS #HealthcareInnovation #LifeSciences #DigitalHealth #PrecisionMedicine #GeneTherapies #ClinicalTrials #RealWorldEvidence #thoughtleadership #innovation #healthsciences #himss24 #research #medicaldevices #medtech #healthcareinnovation #medicine Cognizant Devashish Rudra Bhushan Joshi Meiyappan Adaikkalavan James Cich, MBA Mo Ebrahim, PMP, CSM Jay Purasawalkam Sivaramakrishnan Nochur Tariq Shah Dr. Seema Nair S. Meryl Robin Sanjeev Kulkarni Tom Condon Josh Voluck Barry Markwick Adam B. Bryan Hill Bill Brennan

Dive into the Future of Healthcare! Curious about how strategic partnerships and incubation at Johnson & Johnson Innovation – JLABS can empower startups to reshape patient care? Have a look at the great blog of Elena Fernandez Kleinlein and share your thoughts with us! #PrecisionMedicine #JnJinnovation #Collaboration 🚀🔬

Atropos Health Expands Evidence Network With New Partners And Customer Learn more & get our take 👇 https://lnkd.in/gWk-Wvxw “We are excited to welcome these new partners to the Atropos Evidence Network. As the largest federated healthcare data network, our commitment to members is to reduce data security and identity management risks, bring them great tools to add automation, efficiency, and transparency to their own processes, and allow them to create value for the significant investments they have made in data quality and data enrichment.” — Dr. Brigham Hyde, CEO and co-Founder at Atropos Health “Our partnership with Atropos Health underscores our commitment to advancing precision medicine by leveraging Syndesis Health’s extensive datasets. With data spanning 15 countries outside of the US and approximately 35 million patients, we are uniquely positioned to ensure that the advancements in precision medicine reflect both geographic and ethnic diversity.” — Josh Sutton, CEO at Syndesis Health “This collaboration will enable us to leverage high-quality real-world data to optimize clinical trial designs and improve patient outcomes. By integrating Atropos Health’s innovative tools and extensive data sets, we can accelerate the development of new oncology therapies and bring them to patients with greater precision and speed.” — Stephen Gately, PhD, President and CEO at Translational Drug Development (TD2) #growth #healthcare #SoHCNews

𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗶𝘀 𝘂𝗻𝗱𝗲𝗻𝗶𝗮𝗯𝗹𝘆 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲, 𝗯𝘂𝘁 𝗶𝘁𝘀 𝗳𝘂𝗹𝗹 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗿𝗲𝗺𝗮𝗶𝗻𝘀 𝘂𝗻𝘁𝗮𝗽𝗽𝗲𝗱. While we've made significant strides in understanding the genetic underpinnings of diseases and developing targeted therapies, translating these discoveries into routine clinical practice presents substantial challenges. Data integration, interdisciplinary collaboration, and ethical considerations are just a few of the hurdles we must overcome. Additionally, ensuring equitable access to precision medicine for all patients is paramount. By fostering innovation, investing in research, and addressing these challenges head-on, we can accelerate the realization of personalized healthcare. I'm eager to connect with professionals who share my passion for precision medicine. Let's discuss how we can collaborate to shape the future of healthcare together. #precisionmedicine #healthcare #medicine #clinicalpractice #biomedicalresearch #innovation #healthcareaccess

In today’s healthcare environment, I firmly believe most future interventions will have a precision medicine component that will help patients get the personalized treatments. Strategic collaborations are essential in developing these transformational innovations successfully. It is vital that collaborators align on the potential of their idea to be a transformational solution for patients and that they are all committed to the journey.   In this blog I reflect on opportunities and challenges that precision medicine start-ups may encounter, and on how incubation through Johnson & Johnson Innovation – JLABS might support these start-ups. I invite you to read the blog and share your insights: https://lnkd.in/dQvXmWub   #precisionmedicine #jnjinnovation #mycompany    

An insightful read for those in the Life Sciences, exploring the integral role of #PrecisionMedicine in the future of #Healthcare. Discover how the Johnson and Johnson Innovation - JLABS incubation model can support start-ups navigate this area of innovation. #LifeSciences #Innovation #Collaboration #jnjinnovation #mycompany

We are excited to be showcasing CapsicoHealth's Pathways 2.0 LLMs for precision medicine and patient journeys, at the GenAI Summit in SF next week (May 29th-31st). Looking forward to meeting colleagues and partners at SF's Palace of Fine Arts on Gen-AI's impact, value, transparency, and responsible-AI processes for Life sciences and Healthcare. CapsicoHealth has taken a giant step forward in bringing RWD based real-time cohort and pathways tools, and Gen-AI driven assistant/chat-apps to simplify diagnostic, treatment and adoption insights for Pharma and Healthcare stakeholders including market access. Our core vision is to enable timely and actionable knowledge on the right treatment and care to the right patient. Stay tuned as we have more news on our Gen-AI tools being made available for interested parties, and upcoming validation reports. #healthcareai hashtag #aiareall hashtag #aiforhealth hashtag #ai4health hashtag #healthcare hashtag #pharma #health

Minority Groups Remain Underrepresented in Vitiligo Trials, Study Finds (https://lnkd.in/eRwvxUB) Clinical trials are the backbone of medical advancements, yet they remain fundamentally flawed when lacking diverse representation. It is imperative to include individuals from all backgrounds to ensure the findings are universally applicable and beneficial. Diverse clinical trials lead to better healthcare outcomes, uncovering unknown drug interactions, and providing insights into how treatments can be tailored for different genetic makeups. We cannot achieve true progress if our research does not reflect the full spectrum of humanity. #InclusiveResearch #HealthEquity #ClinicalTrialsMatter

Are the #clinicaltrials in today's modern era highly anticipated for patients & researchers? The answer could vary depending on resource availability and the ability to adopt these technology trends as a priority. Executing complex clinical trials within designated timelines is crucial, but budget constraints often cause unforeseen delays. While patient recruitment has been a significant bottleneck in clinical trials, innovators like Jeeva Clinical Trials Inc. implicitly try new trends to achieve positive patient recruitment and retention, which can be a trend for the coming years. Learn more about the trends from Clinical Leader's article: https://lnkd.in/gCBuG5jg #patientengagement #researchtrends #patientrecruitmentinUSA #virtualtrials #gamification